Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors
<p>Glioblastoma patient characteristics (DFCI)</p>
שמור ב:
| מחבר ראשי: | |
|---|---|
| מחברים אחרים: | , , , , , , , , , |
| יצא לאור: |
2025
|
| נושאים: | |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
| _version_ | 1849927632882237440 |
|---|---|
| author | Joseph Toker (15399882) |
| author2 | J. Bryan Iorgulescu (15030477) Alexander L. Ling (15399885) Genaro R. Villa (15399888) Josephina A.M.A. Gadet (15399891) Laxmi Parida (15112564) Gad Getz (14945542) Catherine J. Wu (14944480) David A. Reardon (15043854) E. Antonio Chiocca (15399894) Marco Mineo (15399897) |
| author2_role | author author author author author author author author author author |
| author_facet | Joseph Toker (15399882) J. Bryan Iorgulescu (15030477) Alexander L. Ling (15399885) Genaro R. Villa (15399888) Josephina A.M.A. Gadet (15399891) Laxmi Parida (15112564) Gad Getz (14945542) Catherine J. Wu (14944480) David A. Reardon (15043854) E. Antonio Chiocca (15399894) Marco Mineo (15399897) |
| author_role | author |
| dc.creator.none.fl_str_mv | Joseph Toker (15399882) J. Bryan Iorgulescu (15030477) Alexander L. Ling (15399885) Genaro R. Villa (15399888) Josephina A.M.A. Gadet (15399891) Laxmi Parida (15112564) Gad Getz (14945542) Catherine J. Wu (14944480) David A. Reardon (15043854) E. Antonio Chiocca (15399894) Marco Mineo (15399897) |
| dc.date.none.fl_str_mv | 2025-11-25T13:11:30Z |
| dc.identifier.none.fl_str_mv | 10.1158/1078-0432.30708094 |
| dc.relation.none.fl_str_mv | https://figshare.com/articles/dataset/Table_S6_from_Clinical_Importance_of_the_lncRNA_i_NEAT1_i_in_Cancer_Patients_Treated_with_Immune_Checkpoint_Inhibitors/30708094 |
| dc.rights.none.fl_str_mv | CC BY info:eu-repo/semantics/openAccess |
| dc.subject.none.fl_str_mv | Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers CNS Cancers Gliomas, Glioblastomas Immunotherapy Checkpoint blockade Skin Cancers Melanoma |
| dc.title.none.fl_str_mv | Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors |
| dc.type.none.fl_str_mv | Dataset info:eu-repo/semantics/publishedVersion dataset |
| description | <p>Glioblastoma patient characteristics (DFCI)</p> |
| eu_rights_str_mv | openAccess |
| id | Manara_d11cd3dbef97fb37185bf8028cbd47b1 |
| identifier_str_mv | 10.1158/1078-0432.30708094 |
| network_acronym_str | Manara |
| network_name_str | ManaraRepo |
| oai_identifier_str | oai:figshare.com:article/30708094 |
| publishDate | 2025 |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | CC BY |
| spelling | Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint InhibitorsJoseph Toker (15399882)J. Bryan Iorgulescu (15030477)Alexander L. Ling (15399885)Genaro R. Villa (15399888)Josephina A.M.A. Gadet (15399891)Laxmi Parida (15112564)Gad Getz (14945542)Catherine J. Wu (14944480)David A. Reardon (15043854)E. Antonio Chiocca (15399894)Marco Mineo (15399897)CancerCancer Detection and DiagnosisImmuno-oncologyBiomarkersCNS CancersGliomas, GlioblastomasImmunotherapyCheckpoint blockadeSkin CancersMelanoma<p>Glioblastoma patient characteristics (DFCI)</p>2025-11-25T13:11:30ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30708094https://figshare.com/articles/dataset/Table_S6_from_Clinical_Importance_of_the_lncRNA_i_NEAT1_i_in_Cancer_Patients_Treated_with_Immune_Checkpoint_Inhibitors/30708094CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307080942025-11-25T13:11:30Z |
| spellingShingle | Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors Joseph Toker (15399882) Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers CNS Cancers Gliomas, Glioblastomas Immunotherapy Checkpoint blockade Skin Cancers Melanoma |
| status_str | publishedVersion |
| title | Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors |
| title_full | Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors |
| title_fullStr | Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors |
| title_full_unstemmed | Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors |
| title_short | Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors |
| title_sort | Table S6 from Clinical Importance of the lncRNA <i>NEAT1</i> in Cancer Patients Treated with Immune Checkpoint Inhibitors |
| topic | Cancer Cancer Detection and Diagnosis Immuno-oncology Biomarkers CNS Cancers Gliomas, Glioblastomas Immunotherapy Checkpoint blockade Skin Cancers Melanoma |